US Patent Issued to Navolab Diagnosztika Kft. on March 31 for "Assessing responsiveness of rheumatoid arthritis patients to biological treatment" (Hungarian Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,958, issued on March 31, was assigned to Navolab Diagnosztika Kft. (Szeged, Hungary).

"Assessing responsiveness of rheumatoid arthritis patients to biological treatment" was invented by Gergely Toldi (Budapest, Hungary), Kata Filkor (Salgotarjan, Hungary), Peter Szeremy (Szeged, Hungary), Andras Apjok (Szeged, Hungary) and Zoltan Szekanecz (Debrecen, Hungary).

According to the abstract* released by the U.S. Patent & Trademark Office: "The relates to the field of diagnosis and treatment of Rheumatoid Arthritis, in particular of assessing responsiveness of rheumatoid arthritis patients to biological treatment. In particular the it has been found that measurement of MDR1 and/or MRP...